Correlation between low tapasin expression and impaired CD8+ T‑cell function in patients with chronic hepatitis B

Tang,Yuyan; Wang,Jieling; Zhang,Yi; Zhuo,Meng; Song,Linlin; Tang,Zhenghao; Zang,Guoqing; Chen,Xiaohua; Yu,Yongsheng

doi:10.3892/mmr.2016.5610

Correlation between low tapasin expression and impaired CD8+ T‑cell function in patients with chronic hepatitis B

Authors:
- Yuyan Tang
- Jieling Wang
- Yi Zhang
- Meng Zhuo
- Linlin Song
- Zhenghao Tang
- Guoqing Zang
- Xiaohua Chen
- Yongsheng Yu
View Affiliations

Affiliations: Department of Infectious Disease, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, P.R. China
Published online on: August 9, 2016 https://doi.org/10.3892/mmr.2016.5610
Pages: 3315-3322

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Recent studies have demonstrated that chronic hepatitis B virus (HBV) infection is associated with reduced antigen‑presenting capacity and insufficient cytotoxic T lymphocyte (CTL) production. The molecular chaperone tapasin mediates binding of the transporter associated with antigen processing (TAP), and has an important role in endogenous antigen processing and presentation, and the induction of specific CTL responses. The present study aimed to determine whether tapasin is associated with chronic HBV (CHB) infection. The mRNA expression levels of tapasin were detected in peripheral blood mononuclear cells from 27 patients with CHB, 20 patients with acute HBV (AHB) and 26 healthy controls by reverse transcription‑quantitative polymerase chain reaction. In addition, CD8+ T immune responses were evaluated in all groups, and the correlation between tapasin expression and CD8+ responses was analyzed. The results demonstrated that the mRNA expression levels of tapasin were significantly downregulated in patients with CHB compared with in healthy controls and patients with AHB. Furthermore, the apoptotic rate of CD8+ T cells was increased in patients with CHB compared with in the other two groups. The percentage of interferon (IFN)‑γ+CD8+ T cells was reduced in patients with CHB compared with in patients with AHB and healthy controls, and serum cytokine levels (IFN‑γ, interleukin‑2 and tumor necrosis factor‑α) were generally low in patients with CHB. Furthermore, the mRNA expression levels of tapasin were positively correlated with IFN‑γ production by CD8+ T cells, and were inversely correlated with the apoptotic ratio of CD8+ T cells. These results indicate that decreased expression of tapasin may be closely associated with CHB, and suggest an important role for tapasin in the pathogenesis of CHB.

View Figures

View References

1	Chen X, Liu H, Tang Z, Yu Y and Zang G: The modification of Tapasin enhances cytotoxic T lymphocyte activity of intracellularly delivered CTL epitopes via cytoplasmic transduction peptide. Acta Biochim Biophys Sin (Shanghai). 45:203–212. 2013. View Article : Google Scholar
2	Wang FS, Fan JG, Zhang Z, Gao B and Wang HY: The global burden of liver disease: The major impact of China. Hepatology. 60:2099–2108. 2014. View Article : Google Scholar : PubMed/NCBI
3	Chisari FV, Isogawa M and Wieland SF: Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris). 58:258–266. 2010. View Article : Google Scholar
4	Ganem D and Prince AM: Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med. 350:1118–1129. 2004. View Article : Google Scholar : PubMed/NCBI
5	Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH and Chisari FV: CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol. 77:68–76. 2003. View Article : Google Scholar :
6	Asabe S, Chattopadhyay PK, Roederer M, Engle RE, Purcell RH and Chisari FV: The size of the viral inoculum contributes to the outcome of hepatitis B virus infection. J Virol. 83:9652–9662. 2009. View Article : Google Scholar : PubMed/NCBI
7	Phillips S, Chokshi S, Riva A, Evans A, Williams R and Naoumov NV: CD8(+) T cell control of hepatitis B virus replication: Direct comparison between cytolytic and noncytolytic functions. J Immunol. 184:287–295. 2010. View Article : Google Scholar
8	Leonhardt RM, Abrahimi P, Mitchell SM and Cresswell P: Three tapasin docking sites in TAP cooperate to facilitate transporter stabilization and heterodimerization. J Immunol. 192:2480–2494. 2014. View Article : Google Scholar : PubMed/NCBI
9	Hulpke S, Baldauf C and Tampé R: Molecular architecture of the MHC I peptide-loading complex: One tapasin molecule is essential and sufficient for antigen processing. FASEB J. 26:5071–5080. 2012. View Article : Google Scholar : PubMed/NCBI
10	Tang YY, Tang ZH, Zhang Y, Zhuo M, Zang GQ, Chen XH and Yu YS: The fusion protein of CTP-HBcAg18-27-Tapasin mediates the apoptosis of CD8(+)T cells and CD8(+) T cell response in HLA-A2 transgenic mice. Hepat Mon. 14:e161612014. View Article : Google Scholar : PubMed/NCBI
11	Chen X, Tang Y, Zhang Y, Zhuo M, Tang Z, Yu Y and Zang G: Tapasin modification on the intracellular epitope HBcAg18-27 enhances HBV-specific CTL immune response and inhibits hepatitis B virus replication in vivo. Lab Invest. 94:478–490. 2014. View Article : Google Scholar : PubMed/NCBI
12	Steinke JW, Liu L, Turner RB, Braciale TJ and Borish L: Immune surveillance by rhinovirus-specific circulating CD4⁺ and CD8⁺ T lymphocytes. PLoS One. 10:e01152712015. View Article : Google Scholar
13	Ashraf S, Nitschke K, Warshow UM, Brooks CR, Kim AY, Lauer GM, Hydes TJ, Cramp ME, Alexander G, Little AM, et al: Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infection. Hepatology. 58:881–889. 2013. View Article : Google Scholar : PubMed/NCBI
14	Pei J, Tang Z, Zang G and Yu Y: Blockage of Notch1 signaling modulates the T-helper (Th)1/Th2 cell balance in chronic hepatitis B patients. Hepatol Res. 40:799–805. 2010. View Article : Google Scholar : PubMed/NCBI
15	Crawford TQ, Ndhlovu LC, Tan A, Carvidi A, Hecht FM, Sinclair E and Barbour JD: HIV-1 infection abrogates CD8⁺ T cell mitogen-activated protein kinase signaling responses. J Virol. 85:12343–12350. 2011. View Article : Google Scholar : PubMed/NCBI
16	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
17	Rubinstein MP, Lind NA, Purton JF, Filippou P, Best JA, McGhee PA, Surh CD and Goldrath AW: IL-7 and IL-15 differentially regulate CD8⁺ T-cell subsets during contraction of the immune response. Blood. 112:3704–3712. 2008. View Article : Google Scholar : PubMed/NCBI
18	Virgin HW, Wherry EJ and Ahmed R: Redefining chronic viral infection. Cell. 138:30–50. 2009. View Article : Google Scholar : PubMed/NCBI
19	Burns GS and Thompson AJ: Viral hepatitis B: Clinical and epidemiological characteristics. Cold Spring Harb Perspect Med. 4:a0249352014. View Article : Google Scholar : PubMed/NCBI
20	Xie Q, Shen HC, Jia NN, Wang H, Lin LY, An BY, Gui HL, Guo SM, Cai W, Yu H, et al: Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes Infect. 11:515–523. 2009. View Article : Google Scholar : PubMed/NCBI
21	Woltman AM, Op den Brouw ML, Biesta PJ, Shi CC and Janssen HL: Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS One. 6:e153242011. View Article : Google Scholar : PubMed/NCBI
22	Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, Betts MR, Freeman GJ, Vignali DA and Wherry EJ: Coregulation of CD8⁺ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol. 10:29–37. 2009. View Article : Google Scholar
23	Klenerman P and Hill A: T cells and viral persistence: Lessons from diverse infections. Nat Immunol. 6:873–879. 2005. View Article : Google Scholar : PubMed/NCBI
24	Ou R, Zhang M, Huang L and Moskophidis D: Control of virus-specific CD8⁺ T-cell exhaustion and immune-mediated pathology by E3 ubiquitin ligase Cbl-b during chronic viral infection. J Virol. 82:3353–3368. 2008. View Article : Google Scholar : PubMed/NCBI
25	Neefjes J, Jongsma ML, Paul P and Bakke O: Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol. 11:823–836. 2011.PubMed/NCBI
26	Papadopoulos M and Momburg F: Multiple residues in the transmembrane helix and connecting peptide of mouse tapasin stabilize the transporter associated with the antigen-processing TAP2 subunit. J Biol Chem. 282:9401–9410. 2007. View Article : Google Scholar : PubMed/NCBI
27	Cabrera CM: The double role of the endoplasmic reticulum chaperone tapasin in peptide optimization of HLA class I molecules. Scand J Immunol. 65:487–493. 2007. View Article : Google Scholar : PubMed/NCBI
28	Tey SK and Khanna R: Host immune system strikes back: Autophagy-mediated antigen presentation bypasses viral blockade of the classic MHC class I processing pathway. Autophagy. 8:1839–1841. 2012. View Article : Google Scholar : PubMed/NCBI
29	Chen M and Bouvier M: Analysis of interactions in a tapasin/class I complex provides a mechanism for peptide selection. EMBO J. 26:1681–1690. 2007. View Article : Google Scholar : PubMed/NCBI
30	Wearsch PA and Cresswell P: Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat Immunol. 8:873–881. 2007. View Article : Google Scholar : PubMed/NCBI
31	Boulanger DS, Oliveira R, Ayers L, Prior SH, James E, Williams AP and Elliott T: Absence of tapasin alters immunodominance against a lymphocytic choriomeningitis virus polytope. J Immunol. 184:73–83. 2010. View Article : Google Scholar
32	Sa Q, Woodward J and Suzuki Y: IL-2 produced by CD8⁺ immune T cells can augment their IFN-γ production independently from their proliferation in the secondary response to an intracellular pathogen. J Immunol. 190:2199–2207. 2013. View Article : Google Scholar : PubMed/NCBI